| 书目名称 | Cannabis and Cannabinoid-Based Medicines in Cancer Care | | 副标题 | A Comprehensive Guid | | 编辑 | Claude Cyr,Mellar P. Davis,Paul Daeninck | | 视频video | | | 概述 | Reviews both regulated and unregulated CBM.Provides prescription recommendations and guidelines for clinical practitioners.Written by experts in the fields of oncology, pain management, and palliative | | 图书封面 |  | | 描述 | The use of cannabinoid-based medicines (CBM), and cannabis in particular, has risen steadily among cancer and palliative care patients over the last few years. This textbook aims to address the multiple challenges facing healthcare providers regarding the use of CBM in this vulnerable patient population. It provides insight into the latest preclinical and clinical data and offers a practical approach on the use of CBM in a rapidly evolving landscape. It answers questions regarding the prescribing process and elucidates controversies regarding cannabis’ disease-modifying effects. The first chapters will review basic concepts of the endocannabinoid system and pharmacology of CBM, while focusing more specifically on the unique characteristics of two main cannabinoids: THC and CBD. Indicating which benefits can be expected from using either or both of these compounds, the book then addresses issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patientswith polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled | | 出版日期 | Book 2022 | | 关键词 | Cannabinoid Based Medicines; Cancer Symptom Management; THC; CBD; Psychoactive Effects of CBM; Endocannab | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-030-89918-9 | | isbn_softcover | 978-3-030-89917-2 | | isbn_ebook | 978-3-030-89918-9 | | copyright | Springer Nature Switzerland AG 2022 |
The information of publication is updating
|
|
发表于 2025-3-21 19:27:32
